You have 9 free searches left this month | to do more

mbg453

Mbg453 is a drug used to treat Myelodysplastic Syndromes, Acute Myeloid Leukemia, Advanced Malignancies, and other conditions. Mbg453 is being actively studied in 10 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Novartis PharmaceuticalsNovartis Investigative SiteAndrew Mark Brunner, MD
Massachusetts General HospitalDuke University Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMD Anderson Cancer Center/University of Texas MD Anderson
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Not yet recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • Boston, Massachusetts
  • +2 more
2021-03-28
Mar 28, 2021
N
Recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +9 more
2022-03-23
Mar 23, 2022
N
Active, not recruiting
  • Advanced Malignancies
  • MBG453
  • +2 more
  • Baltimore, Maryland
  • +13 more
2022-03-18
Mar 18, 2022
N
Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
2021-10-14
Oct 14, 2021
S
Recruiting
  • Glioblastoma Multiforme
  • MBG453
  • Stanford, California
  • +1 more
2022-04-01
Apr 1, 2022
N
Recruiting
  • Acute Myeloid Leukemia
  • MBG453
  • +2 more
  • San Francisco, California
  • +27 more
2022-03-31
Mar 31, 2022
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • MBG453
  • +3 more
  • (no location specified)
2021-03-02
Mar 2, 2021
N
Recruiting
  • Myelodysplastic Syndrome (MDS)
  • MBG453
  • +3 more
  • Chandler, Arizona
  • +17 more
2022-03-23
Mar 23, 2022
N
Active, not recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • +2 more
  • Duarte, California
  • +46 more
2022-02-01
Feb 1, 2022
N
Recruiting
  • Myelodysplastic Syndromes
  • MBG453
  • +2 more
  • Columbus, Ohio
  • +8 more
2022-02-21
Feb 21, 2022